English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17938/22957 (78%)
Visitors : 7397711      Online Users : 275
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version

    Category

    Loading community tree, please wait....

    Year

    Loading year class tree, please wait....

    Items for Author "Han, CP" 

    Return to Browse by Author

    Showing 14 items.

    Collection Date Title Authors Bitstream
    [中山醫學大學研究成果] 其他文獻 2020 The Her2 gene aberrations in mucinous ovarian carcinoma: Analysis of twenty-one cases Chiu, HH; Chao, WR; Chen, CK; Lee, YJ; Lee, MY; Han, CP
    [中山醫學大學研究成果] 期刊論文 2021 High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients Chao, WR; Lee, YJ; Lee, MY; Sheu, GT; Han, CP
    [醫學系] 期刊論文 2010 Anti-cytokeratin CAM5.2 reagent (Becton Dickinson Biosciences) can detect CK 8, not CK8/18-Comment on "Sonographic findings in a patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor," J Clin Ultrasound 2010 Jan 20 [Epub ahead of print]. Chen, PJ; Hsu, JD; Han, CP
    [醫學系] 期刊論文 2010 HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target. Han, CP; Hsu, JD; Yao, CC; Lee, MY; Ruan, A; Tyan, YS; Yang, SF; Chiang, H
    [醫學系] 期刊論文 2010 The murine monoclonal antibody anti-cytokeratin CAM 5.2 is specific for intracellular cytokeratin 8, not cytokeratin 18. Cheng, WC; Hsu, JD; Yao, CC; Han, CP
    [醫學系] 期刊論文 2010 Becton Dickinson Biosciences CAM5.2 does not stand for true CK8/18. Comment on "Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin", Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:763-7. Wu, YL; Huang, YF; Hsu, JD; Han, CP
    [醫學系] 期刊論文 2010 Anti-Cytokeratin CAM5.2 (BD) does not act as a substitute of the CK8/18 monoclonal antibody. Comment on: 'Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma'. Histopathology 2009; 54; 607-613. Hsu, JD; Yao, CC; Yuan, CC; Lai, CR; Ting, LT; Li, YJ; Han, CP
    [醫學系] 期刊論文 2010 BD (Becton, Dickinson and Company) Biosciences manufactures anticytokeratin CAM5.2, not CK8/18 monoclonal antibody. Liao, CL; Tzeng, SL; Hsu, JD; Chen, PJ; Han, CP
    [醫學系] 期刊論文 2010 True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study. Hsu, JD; Yao, CC; Lee, MY; Kok, LF; Wang, PH; Tyan, YS; Han, CP
    [醫學系] 期刊論文 2010 Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough? Liao, CL; Hsu, JD; Lee, MY; Kok, LF; Li, YJ; Wang, PH; Yao, CC; Han, CP
    [醫學系] 期刊論文 2010 Antibody to cytokeratin (CK8/CK18) is not derived from CAM5.2 clone, and anticytokeratin CAM5.2 (Becton Dickinson) is not synonymous with the antibody (CK8/CK18). Han, CP; Hsu, JD; Koo, CL; Yang, SF
    [醫學系] 期刊論文 2010 Anti-cytokeratin CAM5.2 is not a monoclonal antibody against cytokeratin 8/18. Hsu, JD; Yao, CC; Han, LW; Han, CP
    [醫學系] 期刊論文 2010 Anti-cytokeratin CAM 5.2 is specific for K8 and to a lesser extent for the closely related K7, but shows no reactivity with K18 or K19: comment on: "keratin expression in endocrine organs and their neoplasms" Endocr Pathol. 2009 Spring; 20(1):1-10. Chen, PJ; Hsu, JD; Han, CP
    [醫學系] 期刊論文 2010 Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility. Yi, YC; Chou, PT; Chen, LY; Kuo, WH; Ho, ES; Han, CP; Yang, SF

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback